StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 77.05 B
Share Price
USD 159.11
Avg Daily Volume
902,529
Change (1 day)
0.80%
Change (1 year)
-19.52%
Change (YTD)
-8.71%
CSL Limited Price to Book Ratio (P/B) on July 03, 2025: 4.44
CSL Limited Price to Book Ratio (P/B) is 4.44 on July 03, 2025, a -19.44% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
-
CSL Limited 52-week low Price to Book Ratio (P/B) is 5.87 on July 03, 2025, which is 32.14% above the current Price to Book Ratio (P/B).
-
CSL Limited 52-week low Price to Book Ratio (P/B) is 4.01 on July 03, 2025, which is -9.69% below the current Price to Book Ratio (P/B).
-
CSL Limited average Price to Book Ratio (P/B) for the last 52 weeks is 4.97.
Competitors
Illumina, Inc.
USD 100.34
ILMN
+2.19
2.23%
Revvity, Inc.
USD 100.90
RVTY
+1.87
1.89%
Syngene International Limited
USD 7.45
SYNGENE.NS
-0.01
-0.09%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.09
002317.SZ
-0.09
-4.28%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 3.95
688321.SS
+0.26
6.91%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
RELX Plc
USD 52.55
REL.L
-1.36
-2.53%
Key Data
| Date | Price to Book Ratio (P/B) | Price to Sales Ratio (P/S) | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield |
|---|
Competitors
Illumina, Inc.
USD 100.34
ILMN
+2.19
2.23%
Revvity, Inc.
USD 100.90
RVTY
+1.87
1.89%
Syngene International Limited
USD 7.45
SYNGENE.NS
-0.01
-0.09%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.09
002317.SZ
-0.09
-4.28%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 3.95
688321.SS
+0.26
6.91%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
RELX Plc
USD 52.55
REL.L
-1.36
-2.53%